34% with surgical thrombectomy. The study was carried out as a so-called "target trial analysis" using state-of-the-art statistical methods in order to be able to make the most valid statements ...
This multicenter, prospective study (ClinicalTrials.gov identifier: NCT04703153) enrolled patients across the United States and Singapore. Patients were tested with tissue NGS, LHM, and G360 ctDNA.
Ivonescimab (PD-1/VEGF bispecific antibody) combined with HAIC for first-line treatment of unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II study. TACE with or without ...
Federally funded research suggests that standardizing what defines contamination could increase accuracy of diagnoses, optimize treatments, avoid unnecessary medications and improve patient outcomes ...
Nectero Therapeutics announced today a first-in-human (FIH) multicenter study evaluated treatment of small- to medium-sized abdominal aortic aneurysms (AAA) with pentagalloylglucose (PGG) using its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results